The clinic represents a collaborative effort between the WVU Heart and Vascular Institute and the WVU Department of Medicine to provide cardiology, endocrinology and weight-management services “in a one-stop shop,” according to an Oct. 4 news release from WVU Medicine.
Patients with cardiac disease, pre-diabetes, diabetes or obesity can receive care at the clinic from providers across specialties at one location.
“The novel anti-diabetic medications that have strong cardiovascular outcome data now, more than ever, highlight the importance of a multidisciplinary approach to care,” Smita Kumar, MD, endocrinologist at WVU Medicine said.
GLP-1s have been found to reduce mortality and complications from cardiovascular events, according to a recent study.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
